Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Global equities, oil prices slide on concerns over Europe COVID case counts

Tue, 23rd Mar 2021 14:00

By David Randall

NEW YORK, March 23 (Reuters) - Global equity benchmarks and
oil prices drifted lower Tuesday while safe haven assets gained
as an extended economic lockdown in Germany and U.S. and
European sanctions on China curbed risk appetite worldwide.

Rising concerns over a third wave of the coronavirus
pandemic amid slow vaccine rollouts in Europe hit oil and travel
companies as investors priced in a longer road to recovery.

Germany extended its lockdown until April 18, while
Chancellor Angela Merkel called on citizens to stay at home for
five days over the Easter holidays.

U.S. crude fell 4.04% to $59.07 per barrel and Brent
was at $61.77, down 4.41% on the day.

Energy stocks were also under pressure, with Chevron Corp
, Occidental Petroleum Corp and Exxon Mobil Corp
shedding 1.5% or more, while travel-related stocks fell
as much as 4%.

"Global travel is still looking like it could be a while
away," said Matt Stanley, a fuel broker at Star Fuels in Dubai,
adding that a second-half recovery in oil demand looked doubtful
as lockdowns remain the order of the day.

MSCI's gauge of stocks across the globe shed
0.40% following broad declines in Europe and Asia.

In morning trading on Wall Street, the Dow Jones Industrial
Average fell 63.65 points, or 0.19%, to 32,667.55, the
S&P 500 lost 4.32 points, or 0.11%, to 3,936.27 and the
Nasdaq Composite added 0.96 points, or 0.01%, to
13,378.50.

Benchmark 10 year Treasury yields gained ahead of
Congressional testimony by Federal Reserve Chair Jerome Powell
and Treasury Secretary Janet Yellen later in the day that may
shed light on the pace of economic rebound from the pandemic.

In remarks prepared for delivery to the hearing on Tuesday
morning, Powell said the U.S. economic recovery had progressed
"more quickly than generally expected".

The Congressional hearings begin at 12 p.m. ET (1600 GMT).

"The FOMC last week laid out pretty clearly what the Fed's
view is with regard to rates ... the next thing that markets
will focus on is maybe getting some details from Yellen with
regard to further infrastructure investment," said Alex Wolf,
head of investment strategy for Asia at J.P. Morgan Private
Bank, referring to a statement from the Federal Open Market
Committee.

The dollar index rose 0.385%, with the euro
down 0.44% to $1.1879.

Adding to market concerns were human rights sanctions on
China imposed by the United States, Europe and Britain that
prompted retaliatory sanctions from Beijing.

Worries over the pace of the recovery from the pandemic were
also heightened after a U.S. health agency said the AstraZeneca
Plc vaccine developed with Oxford University may have
included outdated information in its data.

Spot gold dropped 0.3% to $1,733.11 an ounce.

(Reporting by David Randall. Editing by Jane Merriman)

More News
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an oral small molecule PCSK9 inhibitor. Administered on top of rosuvastatin treatment, AZD0780 showed a statistically significant reduction in low-density lipoprotein cholesterol in plasma for test participants with hypercholesterolaemia, Astra says, while no serious adverse events were reported. "Elevated LDL-C levels in plasma is a key risk factor for cardiovascular disease and is estimated to cause 2.6 million deaths worldwide annually," Astra notes.

Read more
28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant said on Tuesday.

Read more
27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in phase III trial on lung cancer. Says the treatment, also known as Dato-DXd, showed a clinically meaningfully improvement in overall survival versus chemotherapy in advanced nonsquamous non-small cell lung cancer. The results build upon the positive progression-free survival findings presented back in 2023, Astra adds.

Read more
22 May 2024 09:53

LONDON BROKER RATINGS: Barclays cuts NextEnergy but lifts JLEN

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
22 May 2024 02:00

British firms expecting hard time in China market, lobby group warns

BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group said on Wednesday, as Beijing strives to halt a retreat in foreign funds from a market once seen as the engine of global growth.

Read more
21 May 2024 19:00

Sector movers: Stocks slip amid light profit-taking

(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in London.

Read more
21 May 2024 17:20

Europe's STOXX 600 ends lower as rate uncertainty prevails

Focus on Fed minutes, Nvidia earnings

*

Read more
21 May 2024 17:04

LONDON MARKET CLOSE: London dips as eyes turn to UK inflation reading

(Alliance News) - Stock prices in London closed in the red on Tuesday, as investors nervously eye a key UK inflation reading, which could prompt the Bank of England to consider interest rate cuts.

Read more
21 May 2024 15:00

London close: Stocks fall ahead of key inflation reading

(Sharecast News) - London stocks ended in negative territory on Tuesday, influenced by the latest UK economic outlook from the International Monetary Fund (IMF) and comments from US Federal Reserve officials.

Read more
21 May 2024 12:03

CORRECT: Stocks fall but pound up as IMF ups UK forecast

(Correcting London Stock Exchange index prices.)

Read more
21 May 2024 12:00

LONDON MARKET MIDDAY: Stocks fall but pound up as IMF ups UK forecast

(Alliance News) - Stock prices in Europe were lower heading into Tuesday afternoon, with shares in New York also set for a muted open, as a recent rally for equities takes a pause.

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 09:04

LONDON MARKET OPEN: FTSE 100 declines after Asian stocks fall

(Alliance News) - Stock prices in London opened in the red on Tuesday, with some US interest rate cut optimism cooling after hawkish words from Federal Reserve central bankers.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.